These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 37433674)
1. The Role of [ El Mantani Ordoulidis S; Siampanopoulou M J Nucl Med Technol; 2023 Dec; 51(4):331-332. PubMed ID: 37433674 [TBL] [Abstract][Full Text] [Related]
2. The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. Piga M; Cocco MC; Serra A; Boi F; Loy M; Mariotti S Eur J Endocrinol; 2008 Oct; 159(4):423-9. PubMed ID: 18603573 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Wang J; Zhang R Br J Radiol; 2017 Mar; 90(1071):20160836. PubMed ID: 28106465 [TBL] [Abstract][Full Text] [Related]
5. Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging. Oki GC; Zantut-Wittmann DE; de Oliveira Santos A; Guariento MH; Tambascia MA; de Almeida EA; Amorim BJ; Lima MC; Etchebehere EC; Camargo EE; Ramos CD Clin Nucl Med; 2010 Apr; 35(4):223-7. PubMed ID: 20305407 [TBL] [Abstract][Full Text] [Related]
6. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy. Lind P; Gallowitsch HJ Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519 [TBL] [Abstract][Full Text] [Related]